查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967587

精子计数检测市场－全球产业规模、份额、趋势、机会、预测：按技术、最终用户、地区和竞争对手划分，2021-2031年

Sperm Count Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球精子计数检测市场预计将从 2025 年的 31.3 亿美元成长到 2031 年的 47.1 亿美元，复合年增长率为 7.05%。

该市场涵盖用于评估精子浓度和品质的诊断工具，这些工具既可用于临床，也可用于家庭环境。推动这一市场成长的主要因素是男性不孕症盛行率的上升以及全球精子数量的下降，这使得便捷且频繁的筛检方法变得尤为重要。根据美国泌尿系统协会和生殖医学会2024年的数据，男性因素导致的不孕症在高达60%的夫妇中造成。如此高的盛行率，加上人们对生殖健康意识的不断提高，持续推动对精准诊断方法的需求。

市场概览
预测期 2027-2031
市场规模：2025年 31.3亿美元
市场规模：2031年 47.1亿美元
复合年增长率：2026-2031年 7.05%
成长最快的细分市场 基于智慧型手机
最大的市场 北美洲

儘管临床需求明确，但由于先进的不孕症检测费用高昂，且许多地区缺乏全面的医疗保险，市场扩张面临许多障碍。这种经济负担往往限制了患者获得必要的诊断服务，尤其是在开发中国家。因此，儘管需求旺盛，经济障碍仍使许多人无法获得这些必要的医疗资源，阻碍了精子计数解决方案的广泛应用。

市场驱动因素

男性不孕率上升和精子品质下降是全球精子计数检测市场的主要驱动因素。随着生活方式的改变和环境压力对生殖健康的影响日益加剧，对准确、频繁的精液分析的需求也随之增长。精子参数的惊人变化趋势凸显了这个生物学危机。根据Igyxos Biotherapeutics公司2024年6月发布的报告，自2020年以来，全球精子数量每年下降超过2.6%，较过去几十年1.2%的年降幅有所加快。此外，根据Ferring Pharmaceuticals公司2024年发布的报告，全球约有六分之一的男性患有不孕症，这意味着庞大的患者群体需要可靠的诊断评估。

同时，由于对私人家用不孕症检测套组的需求激增，市场格局正在重塑。越来越多的男性选择提供匿名性和便利性的直接面向消费者的解决方案，从而避免前往传统的临床机构。这项转变的驱动力在于男性不孕症社会污名的消除以及基于智慧型手机的分析技术的普及。主要产业参与者的成长也印证了这些工具的快速普及。例如，Legacy Inc.在2024年7月报告称，该公司已分析了超过25,000份精液样本，并获得了750万美元的新资金筹措。居家检体采集方式的兴起正在推动市场多元化，使服务能够惠及尚未接受治疗的人群，并催生出一个全新的主动式生殖健康管理领域。

市场挑战

不孕症诊断费用高昂且缺乏全面的保险报销是全球精子计数检测市场成长的主要障碍。虽然基础筛检看似唾手可得，但这通常只是昂贵医疗流程中的一步，许多患者仍然难以负担。在生殖医学医疗保险覆盖范围有限或缺乏的地区，经济负担完全落在病人身上。这种经济压力构成了市场准入壁垒，导致患者推迟或放弃必要的诊断程序，并阻碍了开发中国家和低收入者的市场渗透。

近期行业数据也印证了这一经济障碍的严重性。根据美国生殖医学会统计，2024年一个週期的生育治疗平均费用在12,000美元至15,000美元之间。如此高的费用令患者犹豫不决，甚至不敢开始诊断流程，因为他们担心治疗费用会失控。因此，精子计数检测的需求被人为抑制，经济压力迫使许多夫妇彻底放弃生殖健康服务。

市场趋势

人工智慧 (AI) 和机器学习 (ML) 的融合正在从根本上改变全球精子计数检测市场，将精液分析从主观的人工评估转变为高度精确的自动化诊断。这些演算法的进步使得携带式设备能够达到临床等级的精准度，从而可以快速评估精子形态和活力，避免人工观察带来的误差。 2024 年 8 月，莫纳什大学的研究人员开发出一种人工智慧驱动的模型，能够在几秒钟内分析活体精子样本，准确率高达 93%（根据 Knightley 报道），这项技术飞跃尤为引人注目。透过自动化复杂的诊断标准，这些创新正在使检测结果标准化，并提高家庭和临床环境中的数据可靠性。

同时，市场正日益融合远距远端医疗服务，精子计数检测也从一项独立的诊断产品演变为通往综合远距生育治疗的门户。这一趋势弥合了初步筛检和医疗干预之间的鸿沟，数位平台可在检测完成后立即将使用者与生殖泌尿系统无缝连接。这种整合式医疗模式对于涵盖未接受治疗的人至关重要。根据Posterity Health于2024年6月发布的报告显示，美国有超过300万男性患有睪固酮缺乏症，但由于就医障碍，仅有32%的人接受了专业治疗。透过将诊断功能整合到虚拟医疗生态系统中，企业正在消除这些障碍，并确保异常检测结果能够立即转化为可执行的医疗方案。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球精子计数检测市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依技术（显微镜、层析法免疫检测和比色反应、基于智慧型手机的方法、其他方法）
    • 依最终使用者（医院、不孕症治疗中心等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美精子数检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲精子计数检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区精子计数检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲精子计数检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美精子计数检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球精子计数检测市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • DNA Diagnostics Center, Inc.
  • BioMerieux SA
  • Medical Electronic Systems
  • Thermo Fisher Scientific Inc.
  • CooperSurgical, Inc.
  • Vitrolife Sweden AB
  • Hamilton Thorne Inc.
  • Artron Laboratories Inc.
  • Fertility Focus Ltd.
  • MICROPTIC SL

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24332

The Global Sperm Count Test Market is projected to expand from USD 3.13 Billion in 2025 to USD 4.71 Billion by 2031, registering a CAGR of 7.05%. This market encompasses diagnostic tools designed to assess sperm concentration and quality within both clinical and home-based environments. The primary driver of this growth is the increasing prevalence of male infertility and a global decline in sperm counts, which necessitates accessible and frequent screening methods. Data from the American Urological Association and the American Society for Reproductive Medicine in 2024 indicates that male factor infertility contributes to conception difficulties in up to 60 percent of couples. This high prevalence, alongside growing awareness of reproductive health, sustains the demand for accurate diagnostic modalities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.13 Billion
Market Size 2031USD 4.71 Billion
CAGR 2026-20317.05%
Fastest Growing SegmentSmartphone-based
Largest MarketNorth America

Despite the clear clinical need, market expansion faces significant hurdles due to the prohibitive costs of advanced fertility testing and the lack of comprehensive insurance coverage in many regions. This financial strain often limits patient access to essential diagnostic services, particularly in developing economies. Consequently, the broader adoption of sperm count testing solutions is impeded, as economic barriers prevent many individuals from utilizing these necessary healthcare resources despite the evident demand.

Market Driver

The escalating rates of male infertility and declining sperm quality serve as the primary engines propelling the Global Sperm Count Test Market. As lifestyle changes and environmental stressors increasingly impact reproductive health, the urgency for precise and frequent semen analysis has intensified. This biological crisis is highlighted by alarming trends in sperm parameters; according to Igyxos Biotherapeutics in June 2024, global sperm counts have fallen by over 2.6 percent annually since 2020, accelerating from the 1.2 percent annual decrease seen in prior decades. Furthermore, Ferring Pharmaceuticals reported in 2024 that infertility affects approximately one in six people worldwide, creating a substantial patient pool that requires reliable diagnostic evaluation.

Simultaneously, the market is being reshaped by a surging demand for private, at-home fertility testing kits. Men are increasingly opting for direct-to-consumer solutions that offer anonymity and convenience, bypassing traditional clinical settings. This shift is supported by the destigmatization of male infertility and the integration of smartphone-based analysis technologies. The rapid adoption of these tools is evident in the growth of key industry players; for instance, Legacy reported in July 2024 that it has analyzed over 25,000 sperm samples and secured $7.5 million in new financing. This preference for home-based collection is decentralizing the market, allowing providers to reach untreated populations and fostering a new segment of proactive reproductive health management.

Market Challenge

The high cost of fertility diagnostics and the lack of comprehensive insurance reimbursement constitute major obstacles to the growth of the Global Sperm Count Test Market. While basic screenings may seem accessible, they are often merely the first step in a broader, expensive medical journey that remains unaffordable for many patients. In regions where healthcare coverage for reproductive issues is limited or non-existent, the financial burden falls entirely on the patient. This economic pressure creates a significant barrier to entry, causing individuals to delay or forego essential diagnostic procedures and hampering market penetration in developing economies and lower-income demographics.

The severity of this financial deterrent is underscored by recent industry data. According to the American Society for Reproductive Medicine, the average cost for a single cycle of fertility treatment in 2024 ranged between $12,000 and $15,000. This substantial expense often discourages patients from even initiating the diagnostic process due to fears of cascading treatment costs. Consequently, the demand for sperm count tests is artificially suppressed, as economic constraints force many couples to opt out of the reproductive healthcare system entirely.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) is fundamentally transforming the Global Sperm Count Test Market by shifting semen analysis from subjective manual evaluation to high-precision automated diagnostics. These algorithmic advancements embed clinical-grade accuracy into portable devices, enabling rapid assessment of sperm morphology and motility without the variability associated with human observation. This technological leap was highlighted by The Nightly in August 2024, reporting that researchers at Monash University developed an AI-driven model capable of analyzing live sperm samples with 93 percent accuracy in seconds. By automating complex diagnostic criteria, these innovations standardize results across both home-based and clinical environments, enhancing data reliability.

Concurrently, the market is experiencing a convergence with telehealth services, evolving sperm count testing from a standalone diagnostic product into a gateway for comprehensive remote fertility care. This trend bridges the gap between initial screening and medical intervention, as digital platforms now seamlessly connect users with reproductive urologists immediately following test completion. This integrated care model is vital for capturing untreated populations; according to Posterity Health in June 2024, while over 3 million men in the United States suffer from testosterone deficiency, only 32 percent seek professional treatment due to access barriers. By embedding diagnostics within a virtual health ecosystem, companies are removing these hurdles and ensuring that abnormal results trigger immediate, actionable medical pathways.

Key Market Players

  • DNA Diagnostics Center, Inc.
  • BioMerieux SA
  • Medical Electronic Systems
  • Thermo Fisher Scientific Inc.
  • CooperSurgical, Inc.
  • Vitrolife Sweden AB
  • Hamilton Thorne Inc.
  • Artron Laboratories Inc.
  • Fertility Focus Ltd.
  • MICROPTIC S.L.

Report Scope

In this report, the Global Sperm Count Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sperm Count Test Market, By Technique

  • Microscopy
  • Chromatographic Immunoassay and Colorimetric Reaction
  • Smartphone-based
  • Others

Sperm Count Test Market, By End User

  • Hospitals
  • Fertility Centers
  • Others

Sperm Count Test Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sperm Count Test Market.

Available Customizations:

Global Sperm Count Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sperm Count Test Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Microscopy, Chromatographic Immunoassay and Colorimetric Reaction, Smartphone-based, Others)
    • 5.2.2. By End User (Hospitals, Fertility Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Sperm Count Test Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Sperm Count Test Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Sperm Count Test Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Sperm Count Test Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By End User

7. Europe Sperm Count Test Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Sperm Count Test Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By End User
    • 7.3.2. France Sperm Count Test Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Sperm Count Test Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Sperm Count Test Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Sperm Count Test Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By End User

8. Asia Pacific Sperm Count Test Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Sperm Count Test Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By End User
    • 8.3.2. India Sperm Count Test Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Sperm Count Test Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Sperm Count Test Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Sperm Count Test Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By End User

9. Middle East & Africa Sperm Count Test Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Sperm Count Test Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Sperm Count Test Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Sperm Count Test Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By End User

10. South America Sperm Count Test Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Sperm Count Test Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Sperm Count Test Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Sperm Count Test Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Sperm Count Test Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. DNA Diagnostics Center, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BioMerieux SA
  • 15.3. Medical Electronic Systems
  • 15.4. Thermo Fisher Scientific Inc.
  • 15.5. CooperSurgical, Inc.
  • 15.6. Vitrolife Sweden AB
  • 15.7. Hamilton Thorne Inc.
  • 15.8. Artron Laboratories Inc.
  • 15.9. Fertility Focus Ltd.
  • 15.10. MICROPTIC S.L.

16. Strategic Recommendations

17. About Us & Disclaimer